 | • レポートコード：QY2203B02389 • 出版社/出版日：QYResearch / 2022年3月11日 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のカルベジロール薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカルベジロール薬の世界市場のxxx％を占める「注射剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「小売薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のカルベジロール薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのカルベジロール薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのカルベジロール薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 カルベジロール薬のグローバル主要メーカーには、Novartis、AstraZeneca、GlaxoSmithKline、Bristol-Myers Squibb、Mylan、Johnson & Johnson、Bayer、Merck、Sanofi、Ranbaxyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 カルベジロール薬市場は、種類と用途によって区分されます。世界のカルベジロール薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 注射剤、カプセル、錠剤 【用途別セグメント】 小売薬局、病院薬局、オンライン薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - カルベジロール薬製品概要 - 種類別市場（注射剤、カプセル、錠剤） - 用途別市場（小売薬局、病院薬局、オンライン薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のカルベジロール薬販売量予測2017-2028 - 世界のカルベジロール薬売上予測2017-2028 - カルベジロール薬の地域別販売量 - カルベジロール薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別カルベジロール薬販売量 - 主要メーカー別カルベジロール薬売上 - 主要メーカー別カルベジロール薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（注射剤、カプセル、錠剤） - カルベジロール薬の種類別販売量 - カルベジロール薬の種類別売上 - カルベジロール薬の種類別価格 ・用途別市場規模（小売薬局、病院薬局、オンライン薬局、その他） - カルベジロール薬の用途別販売量 - カルベジロール薬の用途別売上 - カルベジロール薬の用途別価格 ・北米市場 - 北米のカルベジロール薬市場規模（種類別、用途別） - 主要国別のカルベジロール薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのカルベジロール薬市場規模（種類別、用途別） - 主要国別のカルベジロール薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のカルベジロール薬市場規模（種類別、用途別） - 主要国別のカルベジロール薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のカルベジロール薬市場規模（種類別、用途別） - 主要国別のカルベジロール薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのカルベジロール薬市場規模（種類別、用途別） - 主要国別のカルベジロール薬市場規模（トルコ、サウジアラビア） ・企業情報 Novartis、AstraZeneca、GlaxoSmithKline、Bristol-Myers Squibb、Mylan、Johnson & Johnson、Bayer、Merck、Sanofi、Ranbaxy ・産業チェーン及び販売チャネル分析 - カルベジロール薬の産業チェーン分析 - カルベジロール薬の原材料 - カルベジロール薬の生産プロセス - カルベジロール薬の販売及びマーケティング - カルベジロール薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - カルベジロール薬の産業動向 - カルベジロール薬のマーケットドライバー - カルベジロール薬の課題 - カルベジロール薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Carvedilol Drug Market
Due to the COVID-19 pandemic, the global Carvedilol Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Injectables accounting for % of the Carvedilol Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Retail Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Carvedilol Drug market size is valued at US$ million in 2021, while the US and Europe Carvedilol Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Carvedilol Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Carvedilol Drug include Novartis, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Mylan, Johnson & Johnson, Bayer, Merck and Sanofi and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Carvedilol Drug Scope and Segment
Carvedilol Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Carvedilol Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Injectables
Capsules
Tablets
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Others
By Company
Novartis
AstraZeneca
GlaxoSmithKline
Bristol-Myers Squibb
Mylan
Johnson & Johnson
Bayer
Merck
Sanofi
Ranbaxy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Carvedilol Drug Product Introduction
1.2 Market by Type
1.2.1 Global Carvedilol Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injectables
1.2.3 Capsules
1.2.4 Tablets
1.3 Market by Application
1.3.1 Global Carvedilol Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Carvedilol Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Carvedilol Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Carvedilol Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Carvedilol Drug Sales by Region
2.4.1 Global Carvedilol Drug Sales by Region (2017-2022)
2.4.2 Global Sales Carvedilol Drug by Region (2023-2028)
2.5 Global Carvedilol Drug Revenue by Region
2.5.1 Global Carvedilol Drug Revenue by Region (2017-2022)
2.5.2 Global Carvedilol Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Carvedilol Drug Sales by Manufacturers
3.1.1 Global Top Carvedilol Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Carvedilol Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Carvedilol Drug in 2021
3.2 Global Carvedilol Drug Revenue by Manufacturers
3.2.1 Global Carvedilol Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Carvedilol Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Carvedilol Drug Revenue in 2021
3.3 Global Carvedilol Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Carvedilol Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Carvedilol Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Carvedilol Drug Sales by Type
4.1.1 Global Carvedilol Drug Historical Sales by Type (2017-2022)
4.1.2 Global Carvedilol Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Carvedilol Drug Sales Market Share by Type (2017-2028)
4.2 Global Carvedilol Drug Revenue by Type
4.2.1 Global Carvedilol Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Carvedilol Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Carvedilol Drug Revenue Market Share by Type (2017-2028)
4.3 Global Carvedilol Drug Price by Type
4.3.1 Global Carvedilol Drug Price by Type (2017-2022)
4.3.2 Global Carvedilol Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Carvedilol Drug Sales by Application
5.1.1 Global Carvedilol Drug Historical Sales by Application (2017-2022)
5.1.2 Global Carvedilol Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Carvedilol Drug Sales Market Share by Application (2017-2028)
5.2 Global Carvedilol Drug Revenue by Application
5.2.1 Global Carvedilol Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Carvedilol Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Carvedilol Drug Revenue Market Share by Application (2017-2028)
5.3 Global Carvedilol Drug Price by Application
5.3.1 Global Carvedilol Drug Price by Application (2017-2022)
5.3.2 Global Carvedilol Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Carvedilol Drug Market Size by Type
6.1.1 North America Carvedilol Drug Sales by Type (2017-2028)
6.1.2 North America Carvedilol Drug Revenue by Type (2017-2028)
6.2 North America Carvedilol Drug Market Size by Application
6.2.1 North America Carvedilol Drug Sales by Application (2017-2028)
6.2.2 North America Carvedilol Drug Revenue by Application (2017-2028)
6.3 North America Carvedilol Drug Market Size by Country
6.3.1 North America Carvedilol Drug Sales by Country (2017-2028)
6.3.2 North America Carvedilol Drug Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Carvedilol Drug Market Size by Type
7.1.1 Europe Carvedilol Drug Sales by Type (2017-2028)
7.1.2 Europe Carvedilol Drug Revenue by Type (2017-2028)
7.2 Europe Carvedilol Drug Market Size by Application
7.2.1 Europe Carvedilol Drug Sales by Application (2017-2028)
7.2.2 Europe Carvedilol Drug Revenue by Application (2017-2028)
7.3 Europe Carvedilol Drug Market Size by Country
7.3.1 Europe Carvedilol Drug Sales by Country (2017-2028)
7.3.2 Europe Carvedilol Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Carvedilol Drug Market Size by Type
8.1.1 Asia Pacific Carvedilol Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Carvedilol Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Carvedilol Drug Market Size by Application
8.2.1 Asia Pacific Carvedilol Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Carvedilol Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Carvedilol Drug Market Size by Region
8.3.1 Asia Pacific Carvedilol Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Carvedilol Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Carvedilol Drug Market Size by Type
9.1.1 Latin America Carvedilol Drug Sales by Type (2017-2028)
9.1.2 Latin America Carvedilol Drug Revenue by Type (2017-2028)
9.2 Latin America Carvedilol Drug Market Size by Application
9.2.1 Latin America Carvedilol Drug Sales by Application (2017-2028)
9.2.2 Latin America Carvedilol Drug Revenue by Application (2017-2028)
9.3 Latin America Carvedilol Drug Market Size by Country
9.3.1 Latin America Carvedilol Drug Sales by Country (2017-2028)
9.3.2 Latin America Carvedilol Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Carvedilol Drug Market Size by Type
10.1.1 Middle East and Africa Carvedilol Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Carvedilol Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Carvedilol Drug Market Size by Application
10.2.1 Middle East and Africa Carvedilol Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Carvedilol Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Carvedilol Drug Market Size by Country
10.3.1 Middle East and Africa Carvedilol Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Carvedilol Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Overview
11.4.3 Bristol-Myers Squibb Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bristol-Myers Squibb Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Overview
11.5.3 Mylan Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Overview
11.8.3 Merck Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Ranbaxy
11.10.1 Ranbaxy Corporation Information
11.10.2 Ranbaxy Overview
11.10.3 Ranbaxy Carvedilol Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ranbaxy Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ranbaxy Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Carvedilol Drug Industry Chain Analysis
12.2 Carvedilol Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Carvedilol Drug Production Mode & Process
12.4 Carvedilol Drug Sales and Marketing
12.4.1 Carvedilol Drug Sales Channels
12.4.2 Carvedilol Drug Distributors
12.5 Carvedilol Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Carvedilol Drug Industry Trends
13.2 Carvedilol Drug Market Drivers
13.3 Carvedilol Drug Market Challenges
13.4 Carvedilol Drug Market Restraints
14 Key Findings in The Global Carvedilol Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Carvedilol Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Injectables
Table 3. Major Manufacturers of Capsules
Table 4. Major Manufacturers of Tablets
Table 5. Global Carvedilol Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Carvedilol Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Carvedilol Drug Sales by Region (2017-2022) & (K Units)
Table 8. Global Carvedilol Drug Sales Market Share by Region (2017-2022)
Table 9. Global Carvedilol Drug Sales by Region (2023-2028) & (K Units)
Table 10. Global Carvedilol Drug Sales Market Share by Region (2023-2028)
Table 11. Global Carvedilol Drug Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Carvedilol Drug Revenue Market Share by Region (2017-2022)
Table 13. Global Carvedilol Drug Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Carvedilol Drug Revenue Market Share by Region (2023-2028)
Table 15. Global Carvedilol Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Carvedilol Drug Sales Share by Manufacturers (2017-2022)
Table 17. Global Carvedilol Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Carvedilol Drug Revenue Share by Manufacturers (2017-2022)
Table 19. Carvedilol Drug Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Carvedilol Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Carvedilol Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carvedilol Drug as of 2021)
Table 22. Carvedilol Drug Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Carvedilol Drug Product Offered
Table 24. Date of Manufacturers Enter into Carvedilol Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Carvedilol Drug Sales by Type (2017-2022) & (K Units)
Table 27. Global Carvedilol Drug Sales by Type (2023-2028) & (K Units)
Table 28. Global Carvedilol Drug Sales Share by Type (2017-2022)
Table 29. Global Carvedilol Drug Sales Share by Type (2023-2028)
Table 30. Global Carvedilol Drug Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Carvedilol Drug Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Carvedilol Drug Revenue Share by Type (2017-2022)
Table 33. Global Carvedilol Drug Revenue Share by Type (2023-2028)
Table 34. Carvedilol Drug Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Carvedilol Drug Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Carvedilol Drug Sales by Application (2017-2022) & (K Units)
Table 37. Global Carvedilol Drug Sales by Application (2023-2028) & (K Units)
Table 38. Global Carvedilol Drug Sales Share by Application (2017-2022)
Table 39. Global Carvedilol Drug Sales Share by Application (2023-2028)
Table 40. Global Carvedilol Drug Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Carvedilol Drug Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Carvedilol Drug Revenue Share by Application (2017-2022)
Table 43. Global Carvedilol Drug Revenue Share by Application (2023-2028)
Table 44. Carvedilol Drug Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Carvedilol Drug Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Carvedilol Drug Sales by Type (2017-2022) & (K Units)
Table 47. North America Carvedilol Drug Sales by Type (2023-2028) & (K Units)
Table 48. North America Carvedilol Drug Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Carvedilol Drug Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Carvedilol Drug Sales by Application (2017-2022) & (K Units)
Table 51. North America Carvedilol Drug Sales by Application (2023-2028) & (K Units)
Table 52. North America Carvedilol Drug Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Carvedilol Drug Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Carvedilol Drug Sales by Country (2017-2022) & (K Units)
Table 55. North America Carvedilol Drug Sales by Country (2023-2028) & (K Units)
Table 56. North America Carvedilol Drug Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Carvedilol Drug Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Carvedilol Drug Sales by Type (2017-2022) & (K Units)
Table 59. Europe Carvedilol Drug Sales by Type (2023-2028) & (K Units)
Table 60. Europe Carvedilol Drug Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Carvedilol Drug Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Carvedilol Drug Sales by Application (2017-2022) & (K Units)
Table 63. Europe Carvedilol Drug Sales by Application (2023-2028) & (K Units)
Table 64. Europe Carvedilol Drug Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Carvedilol Drug Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Carvedilol Drug Sales by Country (2017-2022) & (K Units)
Table 67. Europe Carvedilol Drug Sales by Country (2023-2028) & (K Units)
Table 68. Europe Carvedilol Drug Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Carvedilol Drug Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Carvedilol Drug Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Carvedilol Drug Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Carvedilol Drug Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Carvedilol Drug Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Carvedilol Drug Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Carvedilol Drug Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Carvedilol Drug Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Carvedilol Drug Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Carvedilol Drug Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Carvedilol Drug Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Carvedilol Drug Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Carvedilol Drug Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Carvedilol Drug Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Carvedilol Drug Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Carvedilol Drug Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Carvedilol Drug Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Carvedilol Drug Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Carvedilol Drug Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Carvedilol Drug Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Carvedilol Drug Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Carvedilol Drug Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Carvedilol Drug Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Carvedilol Drug Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Carvedilol Drug Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Carvedilol Drug Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Carvedilol Drug Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Carvedilol Drug Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Carvedilol Drug Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Carvedilol Drug Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Carvedilol Drug Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Carvedilol Drug Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Carvedilol Drug Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Carvedilol Drug Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Carvedilol Drug Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Carvedilol Drug Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Carvedilol Drug Revenue by Country (2023-2028) & (US$ Million)
Table 106. Novartis Corporation Information
Table 107. Novartis Description and Major Businesses
Table 108. Novartis Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Novartis Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Novartis Recent Developments
Table 111. AstraZeneca Corporation Information
Table 112. AstraZeneca Description and Major Businesses
Table 113. AstraZeneca Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. AstraZeneca Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. AstraZeneca Recent Developments
Table 116. GlaxoSmithKline Corporation Information
Table 117. GlaxoSmithKline Description and Major Businesses
Table 118. GlaxoSmithKline Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. GlaxoSmithKline Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. GlaxoSmithKline Recent Developments
Table 121. Bristol-Myers Squibb Corporation Information
Table 122. Bristol-Myers Squibb Description and Major Businesses
Table 123. Bristol-Myers Squibb Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Bristol-Myers Squibb Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Bristol-Myers Squibb Recent Developments
Table 126. Mylan Corporation Information
Table 127. Mylan Description and Major Businesses
Table 128. Mylan Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Mylan Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Mylan Recent Developments
Table 131. Johnson & Johnson Corporation Information
Table 132. Johnson & Johnson Description and Major Businesses
Table 133. Johnson & Johnson Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Johnson & Johnson Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Johnson & Johnson Recent Developments
Table 136. Bayer Corporation Information
Table 137. Bayer Description and Major Businesses
Table 138. Bayer Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Bayer Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Bayer Recent Developments
Table 141. Merck Corporation Information
Table 142. Merck Description and Major Businesses
Table 143. Merck Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Merck Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Merck Recent Developments
Table 146. Sanofi Corporation Information
Table 147. Sanofi Description and Major Businesses
Table 148. Sanofi Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Sanofi Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Sanofi Recent Developments
Table 151. Ranbaxy Corporation Information
Table 152. Ranbaxy Description and Major Businesses
Table 153. Ranbaxy Carvedilol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Ranbaxy Carvedilol Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Ranbaxy Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Carvedilol Drug Distributors List
Table 159. Carvedilol Drug Customers List
Table 160. Carvedilol Drug Market Trends
Table 161. Carvedilol Drug Market Drivers
Table 162. Carvedilol Drug Market Challenges
Table 163. Carvedilol Drug Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Carvedilol Drug Product Picture
Figure 3. Global Carvedilol Drug Market Share by Type in 2021 & 2028
Figure 3. Injectables Product Picture
Figure 4. Capsules Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Carvedilol Drug Market Share by Application in 2021 & 2028
Figure 7. Retail Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Online Pharmacies
Figure 10. Others
Figure 11. Carvedilol Drug Report Years Considered
Figure 12. Global Carvedilol Drug Sales 2017-2028 (K Units)
Figure 13. Global Carvedilol Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Carvedilol Drug Revenue 2017-2028 (US$ Million)
Figure 15. Global Carvedilol Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Carvedilol Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Carvedilol Drug Sales Market Share by Region (2023-2028)
Figure 18. North America Carvedilol Drug Sales YoY (2017-2028) & (K Units)
Figure 19. North America Carvedilol Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Carvedilol Drug Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Carvedilol Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Carvedilol Drug Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Carvedilol Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Carvedilol Drug Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Carvedilol Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Carvedilol Drug Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Carvedilol Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Carvedilol Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Carvedilol Drug in the World: Market Share by Carvedilol Drug Revenue in 2021
Figure 30. Global Carvedilol Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Carvedilol Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Carvedilol Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Carvedilol Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Carvedilol Drug Revenue Market Share by Application (2017-2028)
Figure 35. North America Carvedilol Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Carvedilol Drug Revenue Market Share by Type (2017-2028)
Figure 37. North America Carvedilol Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Carvedilol Drug Revenue Market Share by Application (2017-2028)
Figure 39. North America Carvedilol Drug Sales Share by Country (2017-2028)
Figure 40. North America Carvedilol Drug Revenue Share by Country (2017-2028)
Figure 41. United States Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Carvedilol Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Carvedilol Drug Revenue Market Share by Type (2017-2028)
Figure 45. Europe Carvedilol Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Carvedilol Drug Revenue Market Share by Application (2017-2028)
Figure 47. Europe Carvedilol Drug Sales Share by Country (2017-2028)
Figure 48. Europe Carvedilol Drug Revenue Share by Country (2017-2028)
Figure 49. Germany Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 50. France Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Carvedilol Drug Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Carvedilol Drug Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Carvedilol Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Carvedilol Drug Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Carvedilol Drug Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Carvedilol Drug Revenue Share by Region (2017-2028)
Figure 60. China Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 63. India Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Carvedilol Drug Sales Market Share by Type (2017-2028)
Figure 70. Latin America Carvedilol Drug Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Carvedilol Drug Sales Market Share by Application (2017-2028)
Figure 72. Latin America Carvedilol Drug Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Carvedilol Drug Sales Share by Country (2017-2028)
Figure 74. Latin America Carvedilol Drug Revenue Share by Country (2017-2028)
Figure 75. Mexico Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Carvedilol Drug Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Carvedilol Drug Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Carvedilol Drug Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Carvedilol Drug Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Carvedilol Drug Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Carvedilol Drug Revenue Share by Country (2017-2028)
Figure 84. Turkey Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Carvedilol Drug Revenue (2017-2028) & (US$ Million)
Figure 87. Carvedilol Drug Value Chain
Figure 88. Carvedilol Drug Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed